Andrew D. Mosholder

1.3k total citations
38 papers, 743 citations indexed

About

Andrew D. Mosholder is a scholar working on Clinical Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Andrew D. Mosholder has authored 38 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Clinical Psychology, 10 papers in Psychiatry and Mental health and 8 papers in Pharmacology. Recurrent topics in Andrew D. Mosholder's work include Suicide and Self-Harm Studies (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Mental Health Treatment and Access (6 papers). Andrew D. Mosholder is often cited by papers focused on Suicide and Self-Harm Studies (9 papers), Attention Deficit Hyperactivity Disorder (6 papers) and Mental Health Treatment and Access (6 papers). Andrew D. Mosholder collaborates with scholars based in United States, Thailand and United Kingdom. Andrew D. Mosholder's co-authors include Rosemary Johann‐Liang, Tarek A. Hammad, Mary E. Willy, Susan Lu, Kate Gelperin, Lockwood G. Taylor, Mark Avigan, Mark Levenson, Bradley McEvoy and Dianne Murphy and has published in prestigious journals such as American Journal of Psychiatry, PEDIATRICS and Scientific Reports.

In The Last Decade

Andrew D. Mosholder

37 papers receiving 720 citations

Peers

Andrew D. Mosholder

PMH

PHYSI

PPCH

PRM

Ruth Brauer United Kingdom

Alison Evans United Kingdom

Federica Prinelli Italy

Anwar Mulugeta Ethiopia

Chunsong Yang China

Nada Lukkahatai United States

Seunghyong Ryu South Korea

Lester Arguelles United States

Joëlle A. Erkens Netherlands

C. Ron Cantrell United States

Ruth Brauer United Kingdom

Andrew D. Mosholder

182 ×0.9

PMH

128 ×0.8

PHYSI

71 ×0.5

110 ×1.1

PPCH

41 ×0.4

PRM

Citations per year, relative to Andrew D. Mosholder Andrew D. Mosholder (= 1×) peers Ruth Brauer

Countries citing papers authored by Andrew D. Mosholder

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Mosholder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Mosholder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Mosholder more than expected).

Fields of papers citing papers by Andrew D. Mosholder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Mosholder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Mosholder. The network helps show where Andrew D. Mosholder may publish in the future.

Co-authorship network of co-authors of Andrew D. Mosholder

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Mosholder. A scholar is included among the top collaborators of Andrew D. Mosholder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Mosholder. Andrew D. Mosholder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pérez-Vilar, Silvia, Andrew D. Mosholder, Elizabeth R. Smith, et al.. (2024). Antipsychotics and Risk of Acute Respiratory Failure in U.S. Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease. Journal of General Internal Medicine. 40(3). 587–594. 1 indexed citations

Walsh, Colin G., Qingxia Chen, Aileen P. Wright, et al.. (2024). Scalable incident detection via natural language processing and probabilistic language models. Scientific Reports. 14(1). 23429–23429. 1 indexed citations

Mosholder, Andrew D., et al.. (2024). Proton-Pump Inhibitors and Cardiovascular Adverse Events: A Meta-Analysis of Randomized Controlled Trials. The American Journal of Gastroenterology. 120(2). 362–369. 5 indexed citations

Mosholder, Andrew D., et al.. (2023). The use of analgesics for intentional self-poisoning: Trends in U.S. poison center data. Journal of Psychiatric Research. 163. 402–405. 2 indexed citations

Simon, Gregory E., Susan M. Shortreed, Jennifer M. Boggs, et al.. (2022). Accuracy of ICD-10-CM encounter diagnoses from health records for identifying self-harm events. Journal of the American Medical Informatics Association. 29(12). 2023–2031. 19 indexed citations

Mosholder, Andrew D., et al.. (2022). Systematic review of risk of SARS-CoV-2 infection and severity of COVID-19 with therapies approved to treat multiple sclerosis. Neurological Sciences. 43(3). 1557–1567. 12 indexed citations

Welch, Emily C., et al.. (2021). Risk of hospitalized depression and intentional self-harm with brand and authorized generic sertraline. Journal of Affective Disorders. 296. 635–641. 2 indexed citations

Mosholder, Andrew D., Noelle M. Cocoros, Marie C. Bradley, et al.. (2020). Risk of Psychiatric Adverse Events Among Montelukast Users. The Journal of Allergy and Clinical Immunology In Practice. 9(1). 385–393.e12. 43 indexed citations

Taylor, Lockwood G., et al.. (2019). Antipsychotic Use and Stroke. The Journal of Clinical Psychiatry. 80(4). 12 indexed citations

10.

Taylor, Lockwood G., et al.. (2019). A systematic review of validated suicide outcome classification in observational studies. International Journal of Epidemiology. 48(5). 1636–1649. 46 indexed citations

11.

Zhou, Esther H., Sigal Kaplan, Andrew D. Mosholder, et al.. (2013). Antidepressant medication dispensing among montelukast initiators. Journal of Asthma. 50(9). 990–995. 9 indexed citations

12.

Meyer, Tamra E., Lockwood G. Taylor, David J. Graham, et al.. (2012). Neuropsychiatric events in varenicline and nicotine replacement patch users in the M ilitary H ealth S ystem. Addiction. 108(1). 203–210. 38 indexed citations

13.

Borders‐Hemphill, Vicky & Andrew D. Mosholder. (2012). U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic. Influenza and Other Respiratory Viruses. 6(6). e129–33. 8 indexed citations

14.

McMahon, Ann, Mark Levenson, Bradley McEvoy, Andrew D. Mosholder, & Dianne Murphy. (2011). Age and Risks of FDA-Approved Long-Acting β2-Adrenergic Receptor Agonists. PEDIATRICS. 128(5). e1147–e1154. 60 indexed citations

15.

Pamer, Carol, Tarek A. Hammad, Sigal Kaplan, et al.. (2010). Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions. Pharmacoepidemiology and Drug Safety. 19(2). 158–174. 30 indexed citations

16.

Colman, Eric, et al.. (2008). An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system. Pharmacoepidemiology and Drug Safety. 17(11). 1068–1076. 41 indexed citations

17.

Brinker, Allen, Andrew D. Mosholder, Stephanie D. Schech, Margaret Burgess, & Mark Avigan. (2007). Indication and Use of Drug Products Used to Treat Attention-Deficit/Hyperactivity Disorder: A Cross-Sectional Study with Inference on the Likelihood of Treatment in Adulthood. Journal of Child and Adolescent Psychopharmacology. 17(3). 328–333. 8 indexed citations

18.

Mosholder, Andrew D. & Carol Pamer. (2006). Postmarketing Surveillance of Suicidal Adverse Events with Pediatric Use of Antidepressants. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 33–36. 12 indexed citations

19.

Mosholder, Andrew D. & Mary E. Willy. (2006). Suicidal Adverse Events in Pediatric Randomized, Controlled Clinical Trials of Antidepressant Drugs Are Associated with Active Drug Treatment: AMeta-Analysis. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 25–32. 45 indexed citations

20.

Mosholder, Andrew D., et al.. (2003). Lithium Interaction With the Cyclooxygenase 2 Inhibitors Rofecoxib and Celecoxib and Other Nonsteroidal Anti-Inflammatory Drugs. The Journal of Clinical Psychiatry. 64(11). 1328–1334. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact